Life&Style Weekly on MSN
Dave Coulier Announces 2nd Cancer Diagnosis After Beating Non-Hodgkin Lymphoma
Dave Coulier announced he is undergoing treatment for tongue cancer nearly eight months after he beat his battle with ...
The U.S. Food and Drug Administration (FDA) has granted traditional approval to Jaypirca (pirobrutinib) for the treatment of ...
Roger O' Donnell of The Cure performs at Riot Fest 2023 at Douglass Park in Chicago on Sept. 17. The Cure keyboardist Roger O’Donnell revealed his lymphoma diagnosis in a series of posts Sunday on X ...
Blood Cancer United®, formerly The Leukemia & Lymphoma Society, announced today new scientific grants and investments to continue momentum toward cures and a better quality of life for all people with ...
The U.S. Food and Drug Administration (FDA) has approved Epkinly (epcoritamab-bysp) plus Revlimid (lenalidomide) and Rituxan (rituximab) for the treatment of patients with relapsed or refractory ...
The Student Visionaries of the Year campaign cultivates teen leadership while advancing Blood Cancer United's mission. The Student Visionaries of the Year campaign cultivates teen leadership while ...
ROCHESTER, Minn. — Chemotherapy is usually the first treatment doctors try to treat lymphoma, including the two most common forms: non-Hodgkin and Hodgkin. But alternatives to chemotherapy are ...
Non-Hodgin's Lymphoma is the seventh most common cancer in the U.S. Some forms of the disease respond well to the treatment, while others are stubborn and aggressive. Now, a new discovery may change ...
CRANBURY, NJ, Dec. 01, 2025 (GLOBE NEWSWIRE) -- CURE® proudly announces its partnership with Blood Cancer United ®, formerly The Leukemia & Lymphoma Society®, to present the inaugural Blood Cancer ...
The Cure keyboardist Roger O’Donnell revealed his lymphoma diagnosis in a series of posts Sunday on X in honor of September's being Blood Cancer Awareness Month. "In September last year I was ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results